Netenax (Netilmicin)

Netilmicin binds to the bacterial 30S ribosomal subunit, causing misreading of messenger RNA and blocking protein synthesis. This disrupts bacterial growth and leads to cell death, effectively clearing the infection.

The dosing regimen for Netenax is determined by the prescribing clinician based on the severity of the infection, patient age, and response to therapy. The prescriber will specify the number of drops, frequency, and duration.

Safety data for netilmicin in pregnancy and lactation are limited. Use is only recommended if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order Netenax, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Netenax (netilmicin) belongs to the aminoglycoside class and offers broad‑spectrum activity against many Gram‑negative ocular pathogens. Compared with alternatives such as tobramycin, netilmicin may have a slightly lower risk of resistance development, but choice of therapy should be guided by local susceptibility patterns and clinician judgment.

Netenax should be stored at ambient temperature, preferably below 25 °C, in its original container. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and discard any solution that appears discolored or cloudy.

Netenax is applied as eye drops. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and instill the prescribed number of drops into the conjunctival sac. The eye should be gently closed for a few seconds to allow distribution.

Serious adverse events, although rare, include corneal ulceration, vision loss, severe allergic reactions such as anaphylaxis, and systemic nephrotoxicity if significant absorption occurs. Patients should seek immediate medical attention if they experience worsening pain, loss of vision, or signs of a severe allergic response.

Netenax should not be used by individuals with a known hypersensitivity to netilmicin, other aminoglycosides, or any component of the formulation. Caution is also advised in patients with severe renal impairment or those receiving systemic ototoxic medications.